Ra Medical Systems, Inc. (RMED): Price and Financial Metrics

Ra Medical Systems, Inc. (RMED)

Today's Latest Price: $6.97 USD

0.11 (-1.55%)

Updated Jan 15 8:00pm

Add RMED to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 185 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

RMED Stock Summary

  • Ra Medical Systems Inc's market capitalization of $20,668,517 is ahead of only 5.18% of US-listed equities.
  • In terms of volatility of its share price, RMED is more volatile than 99.56% of stocks we're observing.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for RMED comes in at -106.16% -- higher than that of merely 2.59% of stocks in our set.
  • Stocks that are quantitatively similar to RMED, based on their financial statements, market capitalization, and price volatility, are ECOR, XENT, TWOU, WEI, and LEAF.
  • Visit RMED's SEC page to see the company's official filings. To visit the company's web site, go to www.ramed.com.

RMED Stock Price Chart Interactive Chart >

Price chart for RMED

RMED Price/Volume Stats

Current price $6.97 52-week high $67.20
Prev. close $7.08 52-week low $4.25
Day low $6.81 Volume 273,400
Day high $7.18 Avg. volume 215,650
50-day MA $6.43 Dividend yield N/A
200-day MA $11.24 Market Cap 20.35M

Ra Medical Systems, Inc. (RMED) Company Bio

RA Medical Systems, Inc., a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and disposable catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. It also provides Pharos, an excimer laser device that emits highly concentrated ultraviolet light used in the treatment of dermatological skin disorders. The company sells its products primarily through its direct sales force in the United States. Ra Medical Systems, Inc. was founded in 2002 and is based in Carlsbad, California.

RMED Latest News Stream

Event/Time News Detail
Loading, please wait...

RMED Latest Social Stream

Loading social stream, please wait...

View Full RMED Social Stream

Latest RMED News From Around the Web

Below are the latest news stories about Ra Medical Systems Inc that investors may wish to consider to help them evaluate RMED as an investment opportunity.

Ra Medical Systems to Present at H.C. Wainwright Virtual BioConnect Conference

Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, announces that management will present at the H.C. Wainwright Virtual BioConnect Conference.

Yahoo | January 6, 2021

Ra Medical resolves DOJ false claims investigations

Ra Medical Systems closed ([[RMED]] -4.8%) after settling federal and state investigations into whether the company made false marketing claims when seeking FDA clearance for its laser ablation treatment for cardiovascular and skin conditions.The investigation by the U.S. Department of Justice was first disclosed in October 2019, when an audit committee found...

Seeking Alpha | January 4, 2021

Ra Medical Systems Announces Settlement Resolving Previously Announced United States Department of Justice and State Investigations

Ra Medical Systems, Inc. (NYSE American: RMED) today announced it has entered into a settlement agreement that resolves civil False Claims Act claims asserted by the United States Department of Justice in an investigation previously disclosed by the Company. Ra Medical Systems has settled these matters without admitting liability or wrongdoing. The allegations resolved as part of the settlement agreement reached with the U.S. Attorney’s Office for the Eastern District of Michigan pertain to the Company’s marketing of the DABRA laser system and DABRA-related remuneration paid to certain physicians. In connection with this settlement, the Company also has reached tentative agreements with the participating states that, if executed, resolve previously disclosed related investigations condu...

Yahoo | January 4, 2021

A Trio of Net Net Working Capital Stocks

The short term investor may want to consider this trio of companies

Yahoo | December 27, 2020

Ra Medical Systems Announces Transfer of Listing to NYSE American

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems moves to the NYSE American.

Business Wire | December 17, 2020

Read More 'RMED' Stories Here

RMED Price Returns

1-mo -10.53%
3-mo 14.26%
6-mo -31.25%
1-year -84.07%
3-year N/A
5-year N/A
YTD -6.19%
2020 -73.70%
2019 -85.79%
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.6517 seconds.